Vancomycin Utilization Evaluation in a Major Teaching Hospital in West of Iran

Vancomycin Utilization Evaluation in a Major Teaching Hospital in West of Iran

Background: Drug utilization review is defined as an authorized, structured, ongoing review of prescribing, dispensing and use of medication. Vancomycin is a narrow-spectrum glycopeptide anti-infective with activity against many gram-positive organisms such as Staphylococci, group A

Bibliographic Details
Main Authors:	Sajad Khiali, Samira Eskandari, Hadi Hamishehkar, Parham Maroufi, Haleh Rezaee
Format:	Article
Language:	English
Published:	Research Center for Rational Use of Drugs (RCRUD) 2020-06-01
Series:	Journal of Pharmaceutical Care
Subjects:	vancomycin teicoplanin drug utilization evaluation clinical pharmacist antibiotic use antibiotic resistance
Online Access:	https://jpc.tums.ac.ir/index.php/jpc/article/view/327

Similar Items

Molecular evaluation of vanA and vanB genes of enterococci isolates resistant to Vancomycin and Teicoplanin
by: Sh Shahraki, et al.
Published: (2017-05-01)

Vancomycin and Five Broad-spectrum Antibiotic Utilization Evaluation in an Educational Medical Center in One Year
by: SiminDokht Shoaei, et al.
Published: (2015-10-01)

Teicoplanin non-susceptible coagulase-negative staphylococci in a large Australian healthcare network: Implications for treatment with vancomycin
by: W. R. P. L. I. Wijesooriya, et al.
Published: (2017-05-01)

Incidence of teicoplanin adverse drug reactions among patients with vancomycin-associated adverse drug reactions and its risk factors
by: Byung-Keun Kim, et al.
Published: (2020-05-01)

A Silkworm Infection Model for<i> </i>In Vivo<i> </i>Study<i> </i>of Glycopeptide Antibiotics
by: Aurora Montali, et al.
Published: (2020-06-01)

Clinical practice and costs of treating catheter-related infections with teicoplanin or vancomycin
by: Simoens S, et al.
Published: (2006-06-01)

Heterogeneous resistance to vancomycin and teicoplanin among Staphylococcus spp. isolated from bacteremia
by: Ana Paula Ferreira Nunes, et al.

Similar efficacy of vancomycin and teicoplanin in treatment of catheter related infection in hemodialysis patients
by: Mohamad Reza Tamadon, et al.
Published: (2012-09-01)

Genome sequencing analysis of Streptomyces coelicolor mutants that overcome the phosphate-depending vancomycin lethal effect
by: Fernando Santos-Beneit
Published: (2018-06-01)

Overview of the analytical methods for vancomycin and/or teicoplanin determination in biological matrices
by: Stajić Ana, et al.
Published: (2017-01-01)

Epidemiology, treatment and outcomes of bloodstream infection due to vancomycin-resistant enterococci in cancer patients in a vanB endemic setting
by: Ouli Xie, et al.
Published: (2020-03-01)

Comparison of mortality and clinical failure rates between vancomycin and teicoplanin in patients with methicillin-resistant Staphylococcus aureus pneumonia
by: Choi, C.-M, et al.
Published: (2022)

Dynamic Changes of Staphylococcus aureus Susceptibility to Vancomycin, Teicoplanin, and Linezolid in a Central Teaching Hospital in Shanghai, China, 2008–2018
by: Ying Jian, et al.
Published: (2020-05-01)

The Role of Vancomycin on Meningitis
by: Ahmed I. Shatat and P.I.C.U team, et al.
Published: (2014-06-01)

Analytical methods for vancomycin determination in biological fluids and in pharmaceuticals
by: Marta Maria Duarte Carvalho Vila, et al.
Published: (2007-04-01)

Vancomycin Resistant Enterococcus
by: Mehveen Iqbal, et al.
Published: (2019-05-01)

Standard of Care Not Met? Monitoring and Dosing of Vancomycin is Error-Prone
by: Ashton C. Lai, et al.
Published: (2020-07-01)

Adverse effects of vancomycin in children: a review of 22 cases
by: Amélia Gorete Afonso da Costa Reis, et al.

Evaluation of Timing of Vancomycin Surgical Site Infection Prophylaxis with Scheduled Antibiotic
by: Wong, Edric, et al.
Published: (2012)

Investigation of the Minimal Inhibitory Concentration Values of Vancomycin, Teicoplanin and Linezolid among MRSA Isolated from Inpatients by E-test Method
by: Tuğrul HOŞBUL, et al.
Published: (2012-06-01)

Utilization Evaluation of Antimicrobial Agents in Neutropenic Cancer Patients in a Teaching hospital: Urgent of Drug Utilization Evaluation Studies
by: Hadi Hamishehkar, et al.
Published: (2015-10-01)

Vancomycin-loaded oxidized hyaluronic acid and adipic acid dihydrazide hydrogel: Bio-compatibility, drug release, antimicrobial activity, and biofilm model
by: Chun-Hsing Liao, et al.
Published: (2020-08-01)

Vancomycin Utilization Evaluation in a teaching hospital: A case- series study in Iran.
by: Fanak Fahimi, et al.
Published: (2015-10-01)

Chemotranscriptomic Profiling Defines Drug-Specific Signatures of the Glycopeptide Antibiotics Dalbavancin, Vancomycin and Chlorobiphenyl-Vancomycin in a VanB-Type-Resistant Streptomycete
by: Andy Hesketh, et al.
Published: (2021-02-01)

Cochrane meta-analysis: teicoplanin versus vancomycin for proven or suspected infection
by: Diogo Diniz Gomes Bugano, et al.
Published: (2011-09-01)

Novel vancomycin–peptide conjugate as potent antibacterial agent against vancomycin-resistant Staphylococcus aureus
by: Jelinkova P, et al.
Published: (2018-10-01)

Phenotypic modifications in Staphylococcus aureus cells exposed to high concentrations of vancomycin and teicoplanin
by: Fábio D.A. Gonçalves, et al.
Published: (2016-01-01)

<i>Mycobacterium vaccae</i> Adaptation to Disinfectants and Hand Sanitisers, and Evaluation of Cross-Tolerance with Antimicrobials
by: Carla C. C. R. de Carvalho, et al.
Published: (2020-08-01)

Teicoplanin Suppresses Vegetative <i>Clostridioides difficile</i> and Spore Outgrowth
by: Suvash Chandra Ojha, et al.
Published: (2021-08-01)

Evaluation of Timing of Vancomycin Surgical Site Infection Prophylaxis with Scheduled Antibiotic
by: Wong, Edric, et al.
Published: (2012)

Vancomycin Drug Utilization Evaluation in infectious disease ward of Imam Khomeini Hospital
by: Khalili H, et al.
Published: (2007-05-01)

A dual PMMA/calcium sulfate carrier of vancomycin is more effective than PMMA‐vancomycin at inhibiting Staphylococcus aureus growth in vitro
by: Shanchao Luo, et al.
Published: (2020-04-01)

Vancomycin Utilization Evaluation in a Tertiary Teaching Hospital in Mashhad, Iran
by: Mohaddeseh Sadat Ayubi, et al.
Published: (2018-08-01)

Decreased Incidence of Periprosthetic Joint Infection in Total Hip Arthroplasty with Use of Topical Vancomycin
by: David A Crawford, et al.
Published: (2018-10-01)

Characteristics of glycopeptide-resistant Staphylococcus aureus strains isolated from inpatients of three teaching hospitals in Warsaw, Poland
by: Ksenia Szymanek-Majchrzak, et al.
Published: (2018-08-01)

Comparison of vancomycin serum levels prior to and post therapeutic drug monitoring in patients admitted to hospital
by: Kaveh Eslami, et al.
Published: (2021-09-01)

Diversity and Genetic Clonality of Vancomycin and Gentamicin Resistant Enterococci Isolated from Healthy Humans in Iran
by: Nasrin Noohi, et al.
Published: (2019-02-01)

Vancomycin Resistance Pattern of Staphylococcus Aureus among Clinical Samples
by: Saadat, S, et al.
Published: (2015-01-01)

Vancomycin trough level and loading dose
by: Tuon FF, et al.
Published: (2018-11-01)

Nosocomial Infection with Vancomycin-dependent Enterococci
by: Paul A. Tambyah, et al.
Published: (2004-07-01)